Clinical TrialsSearch results
Number of results: 1194
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- neoadjuvant docetaxel, oxaliplatin and S-1 therapy for large type 3 or type 4 gastric cancer
- Gastric cancer
- YAMAGUCHI Toshifumi
- 2019-10-11
Other
- A phase II trial of ramucirumab plus irinotecan for patients with early relapced gastric cancer
- Gastric cancer
- YAMAGUCHI Toshifumi
- 2019-11-06
Recruiting
- Research on the effectiveness and safety of microwave mammography
- breast cancer
- Yamagami Kazuhiko
- 2019-03-26
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Completed
- Clinical usefulness after apicotomy microscope operation with MTA cement
- root cyst, periapical disease
- Yada Mitsue
- 2019-03-04
Completed
- Usefulness of a screening test for pancreatic cancer by detection of gene mutations in duodenal juice collected using secretin and a specially-made catheter following gastrointestinal endoscopy in high-risk individuals
- pancreatic cancer
- Yachida Shinichi
- 2021-01-22
Completed
- Development of a screening test for pancreatic cancer by gastrointestinal endoscopy using synthetic human secretin and a specially-made catheter
- 1. Pancreatic cancer or suspected pancreatic cancer 2. Neither pancreatic cancer nor other cancers
- Yachida Shinichi
- 2021-01-22
Recruiting
- Phase 3 Study of ALXN1850 in Pediatric Participants with HPP Previously Treated with Asfotase Alfa
- Hypophosphatasia
- Wuebbenhorst Hiroaki
- 2023-11-19